Occupational Therapists in Saint Marys, GA Accepting Medicare

10 Occupational Therapists found. Showing 1 - 10

Jenna C Graziano, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 70 Lindsey Ln, Saint Marys, GA 31558 Phone: 912-510-6104    Fax: 912-882-6137

Jennifer Michelle Fine, BS, MOT R//L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 70 Lindsey Ln, Saint Marys, GA 31558 Phone: 912-510-6104    Fax: 912-882-6137

Janine C King, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 70 Lindsey Ln, Saint Marys, GA 31558 Phone: 912-510-6104    Fax: 912-882-6137

Frantz Joseph Kerwin Dor, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 70 Lindsey Ln, Saint Marys, GA 31558 Phone: 912-510-6104    Fax: 912-882-6137

Brittany M Kinser, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 70 Lindsey Ln, Saint Marys, GA 31558 Phone: 912-510-6104    Fax: 912-882-6137

Ms. Jessica Marie Cerstvik, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 70 Lindsey Ln, Saint Marys, GA 31558 Phone: 912-510-6104    Fax: 912-882-6137

Alexandra Elizabeth Loop Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 70 Lindsey Ln, Saint Marys, GA 31558 Phone: 912-510-6104    Fax: 912-882-6137

Ms. Judy Ann Deshea, OTR/L Occupational Therapist - Physical Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2000 Dan Proctor Dr, Saint Marys, GA 31558 Phone: 912-576-6450    Fax: 912-576-6454

Taylor Mae Pinson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 70 Lindsey Ln, Saint Marys, GA 31558 Phone: 912-510-6104    Fax: 912-882-6137

Laila Wahid Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 70 Lindsey Ln, Saint Marys, GA 31558 Phone: 912-510-6104    Fax: 912-882-6137

News Archive

PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced that clinical data with PMX-60056 were presented at the American Heart Association's Arteriosclerosis, Thrombosis, and Vascular Biology Meeting in Chicago on April 28, 2011.

FMBFarma granted exclusive rights to market Ampio's Zertane for PE in Brazil

Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, and FBM Industria Farmaceutica Ltda, a member of the HOSPFAR Group that manufactures, imports and distributes pharmaceuticals in Brazil, today announced a license and distribution agreement providing FMBFarma exclusive rights to market Zertane in Brazil for the treatment of premature ejaculation.

GLP-1 receptor agonist may benefit high-risk diabetes

Research shows that using a glucagon-like peptide-1 receptor agonist instead of a rapid-acting insulin analogue at mealtimes can reduce glycaemic variability in high-risk patients with Type 2 diabetes.

Enbrel outperforms Humira in treating newly diagnosed RA patients: Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Amgen/Pfizer's Enbrel is the leading tumor necrosis factor -alpha inhibitor prescribed in newly diagnosed rheumatoid arthritis patients, outpacing Abbott's Humira in the first three lines of treatment.

Kinex receives FDA approval to begin Phase I study of KX2-391 Ointment for actinic keratosis

Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis. This is the Company's third IND to be allowed by the US FDA in the past 12 months.

Read more Medical News

› Verified 3 days ago